Many Americans suffer from a condition called blepharoptosis, also known as droopy eyelids. According to some research, this disease is known to affect more than 1 in 10 adults over the age of 50. Blepharoptosis, referred to as ptosis, primarily limits the field of vision and can cause other negative effects for those who suffer from the ailment.
Ptosis can be present in either one or both eyes and is either present at birth or acquired over time. There are several causes of congenital ptosis, but the cause for the condition later in life is most often a dysfunction or gradual paralysis of the muscles that elevate the eyelid. An injury to the area around the eye can also be a cause of blepharoptosis.
The eyelid normally only covers 1-2mm of the cornea, but blepharoptosis can cause the eyelid to cover a much larger portion, which leads to loss of vision for those who suffer from the condition. The low-lying upper eyelid decreases the margin for vision and can cause patients to experience a tired appearance, a limitation of their field of vision, and even chronic headaches.
Until now, the only treatment for blepharoptosis was surgery, which was reserved for only the most severe cases. Fortunately, there is a new non-surgical option thanks to Osmotica Pharmaceuticals. A newly developed ophthalmic solution called Upneeq has recently gained FDA approval.
In several early trials, Upneeq was proven to improve the condition for those who participated in the trial while administering the solution just once a day. The good news is that there were no serious adverse effects on the patients in the trials.
As with any prescription medication, there are warnings and precautions associated with Upneeq. There are also a handful of potential interactions when combined with other pharmaceuticals. With Upneeq being commercially available as early as August of this year from a select number of ophthalmologists, patients who are interested in treating their ptosis with this new solution should contact their eye doctor to learn more.
The team at Palmetto Eye & Laser Center is up-to-date on Upneeq and all other treatment options for blepharoptosis. Call Palmetto Eye & Laser Center at 864-583-6381 or use the online contact form to learn more about a wide range of solutions for all your eye care health and vision needs.
